Literature DB >> 25117302

Increased serum levels of GDF-15 associated with mortality and subclinical atherosclerosis in patients on maintenance hemodialysis.

H Yilmaz1, H T Çelik, O M Gurel, M A Bilgic, M Namuslu, H Bozkurt, A Ayyildiz, O Inan, N Bavbek, A Akcay.   

Abstract

BACKGROUND/AIMS: Increased carotid intima-media thickness (CIMT) was shown to be an independent predictor of cardiovascular (CV) mortality in dialysis patients and the general population. Growth differentiation factor 15 (GDF-15), a member of the transforming growth factor superfamily, is produced by cardiomyocytes and atherosclerotic lesions under stress conditions such as inflammation. We assessed associations between serum concentrations of GDF-15, mortality, and CIMT for subclinical atherosclerosis in hemodialysis (HD) patients.
METHODS: A total of 87 patients on maintenance hemodialysis and 45 sex- and age-matched healthy controls were included in this prospective study. Serum GDF-15 levels were measured by ELISA. CIMT was assessed by Doppler ultrasonography. The association between serum GDF-15 levels and mortality was assessed using Cox regression analysis with serum levels categorized into two groups according to the median value (328.18 pg/ml). Patients were followed for 2 years and cause-specific and all-cause mortality were determined.
RESULTS: The median level of serum GDF-15 was significantly higher in HD patients than controls [328 (198-522) vs. 176 (101-289) pg/ml, p < 0.01, respectively]. Serum GDF-15 levels were correlated to CIMT (r = 0.607, p < 0.001), C-reactive protein (CRP; r = 0.250, p = 0.010), HD duration (r = 0.376, p = 0.004), and serum albumin (r = - 0.156, p = 0.030). The multivariate analysis revealed that GDF-15 was found to be an independent variable of CIMT in HD patients. In the study, the serum GDF-15 level was an independent marker of all-cause of mortality when adjusted for age, CRP, and history of diabetes mellitus.
CONCLUSION: The relationship between serum GDF-15, mortality, and carotid artery thickening suggests that GDF-15 may be a novel marker of atherosclerosis, inflammation, and malnutrition in HD patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25117302     DOI: 10.1007/s00059-014-4139-5

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  35 in total

1.  The TGF-β superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism.

Authors:  Samuel N Breit; Heiko Johnen; Andrew D Cook; Vicky W W Tsai; Mohammad G Mohammad; Tamara Kuffner; Hong Ping Zhang; Christopher P Marquis; Lele Jiang; Glen Lockwood; Michelle Lee-Ng; Yasmin Husaini; Liyun Wu; John A Hamilton; David A Brown
Journal:  Growth Factors       Date:  2011-08-11       Impact factor: 2.511

Review 2.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

Review 3.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

Review 4.  Chronic kidney disease: a clinical model of premature aging.

Authors:  Peter Stenvinkel; Tobias E Larsson
Journal:  Am J Kidney Dis       Date:  2013-01-26       Impact factor: 8.860

5.  Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis.

Authors:  Rajnish Mehrotra; Uyen Duong; Sirin Jiwakanon; Csaba P Kovesdy; John Moran; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2011-05-20       Impact factor: 8.860

6.  Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.

Authors:  A Rashid Qureshi; Anders Alvestrand; José C Divino-Filho; Alberto Gutierrez; Olof Heimbürger; Bengt Lindholm; Jonas Bergström
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

7.  Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study.

Authors:  Austin G Stack; Wendy E Bloembergen
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

8.  Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.

Authors:  Maria Lajer; Anders Jorsal; Lise Tarnow; Hans-Henrik Parving; Peter Rossing
Journal:  Diabetes Care       Date:  2010-03-31       Impact factor: 17.152

9.  Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets.

Authors:  Laurence Macia; Vicky Wang-Wei Tsai; Amy D Nguyen; Heiko Johnen; Tamara Kuffner; Yan-Chuan Shi; Shu Lin; Herbert Herzog; David A Brown; Samuel N Breit; Amanda Sainsbury
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

10.  Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study.

Authors:  Brendan J Clark; Todd M Bull; Alexander B Benson; Amanda R Stream; Madison Macht; Jeanette Gaydos; Christina Meadows; Ellen L Burnham; Marc Moss
Journal:  Crit Care       Date:  2013-05-24       Impact factor: 9.097

View more
  13 in total

1.  Association of Growth Differentiation Factor 15 with Mortality in a Prospective Hemodialysis Cohort.

Authors:  Amy S You; Kamyar Kalantar-Zadeh; Lorena Lerner; Tracy Nakata; Nancy Lopez; Lidia Lou; Mary Veliz; Melissa Soohoo; Jennie Jing; Frank Zaldivar; Jeno Gyuris; Danh V Nguyen; Connie M Rhee
Journal:  Cardiorenal Med       Date:  2017-02-02       Impact factor: 2.041

2.  Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.

Authors:  Gang Li; Yan Li; Xiao-Qiu Tan; Peng Jia; Jian Zhao; Dong Liu; Ting Wang; Bin Liu
Journal:  Pediatr Cardiol       Date:  2017-08-18       Impact factor: 1.655

3.  Changes and significance of serum CXCL-16, GDF-15, PLA-2 levels in patients with cerebral infarction.

Authors:  Xiqi Liu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

4.  Serum VEGF-D level is correlated with renal dysfunction and proteinuria in patients with diabetic chronic kidney disease.

Authors:  Thi Thuy Uyen Nguyen; Hyeongwan Kim; Yoon Jung Chae; Jong Hwan Jung; Won Kim
Journal:  Medicine (Baltimore)       Date:  2022-02-18       Impact factor: 1.817

Review 5.  GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective.

Authors:  Ramu Adela; Sanjay K Banerjee
Journal:  J Diabetes Res       Date:  2015-07-27       Impact factor: 4.011

6.  Plasma GDF15 level is elevated in psychosis and inversely correlated with severity.

Authors:  Parvin Kumar; Vincent Millischer; J Carlos Villaescusa; Ida A K Nilsson; Claes-Göran Östenson; Martin Schalling; Urban Ösby; Catharina Lavebratt
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

7.  Education and Lifestyle Factors Are Associated with DNA Methylation Clocks in Older African Americans.

Authors:  Wei Zhao; Farah Ammous; Scott Ratliff; Jiaxuan Liu; Miao Yu; Thomas H Mosley; Sharon L R Kardia; Jennifer A Smith
Journal:  Int J Environ Res Public Health       Date:  2019-08-28       Impact factor: 3.390

8.  Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach.

Authors:  Axel C Carlsson; Christoph Nowak; Lars Lind; Carl Johan Östgren; Fredrik H Nyström; Johan Sundström; Juan Jesus Carrero; Ulf Riserus; Erik Ingelsson; Tove Fall; Johan Ärnlöv
Journal:  Ups J Med Sci       Date:  2019-12-05       Impact factor: 2.384

9.  Growth Differentiation Factor 15: A Biomarker with High Clinical Potential in the Evaluation of Kidney Transplant Candidates.

Authors:  Marina de Cos Gomez; Adalberto Benito Hernandez; Maria Teresa Garcia Unzueta; Jaime Mazon Ruiz; Covadonga Lopez Del Moral Cuesta; Jose Luis Perez Canga; David San Segundo Arribas; Rosalia Valero San Cecilio; Juan Carlos Ruiz San Millan; Emilio Rodrigo Calabia
Journal:  J Clin Med       Date:  2020-12-20       Impact factor: 4.241

10.  CRP Stimulates GDF15 Expression in Endothelial Cells through p53.

Authors:  Yoonseo Kim; Nicole Noren Hooten; Michele K Evans
Journal:  Mediators Inflamm       Date:  2018-06-03       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.